Physicians Question Future of TNF Inhibitors for Psoriasis, PsA Physicians Question Future of TNF Inhibitors for Psoriasis, PsA

Two dermatologists and two rheumatologists debate the merits of using IL-17 and IL-23 inhibitors ahead of TNF inhibitors for the treatment of psoriasis and psoriatic arthritis.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news